Literature DB >> 8593560

Familial aspects of Caffey's disease.

R M Bernstein1, D J Zaleske.   

Abstract

Caffey's disease is a cortical hyperostosis, which presents during infancy. Etiology remains unclear. Familial occurrence has been documented in the literature. Reported here is infantile cortical hyperostosis that occurred in a father and his two daughters. The familial occurrence would suggest a genetic basis for Caffey's disease; however, it remains consistent with infection by an agent with a long latency period as has been strongly suggested in Paget's disease.

Entities:  

Mesh:

Year:  1995        PMID: 8593560

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  5 in total

1.  A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Authors:  Robert C Gensure; Outi Mäkitie; Catherine Barclay; Catherine Chan; Steven R Depalma; Murat Bastepe; Hilal Abuzahra; Richard Couper; Stefan Mundlos; David Sillence; Leena Ala Kokko; Jonathan G Seidman; William G Cole; Harald Jüppner
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

2.  Caffey disease or infantile cortical hyperostosis: a case report.

Authors:  Narayanan Kutty; Doylene Thomas; Lionel George; Thomas B John
Journal:  Oman Med J       Date:  2010-04

3.  Caffey's disease: an unusual cause for concern.

Authors:  F J Shannon; M Murphy; I Atchia; E Phelan; E E Fogarty
Journal:  Ir J Med Sci       Date:  2007-05-03       Impact factor: 1.568

4.  Caffey disease with raised immunoglobulin levels and thrombocytosis.

Authors:  T Sathish Kumar; Julius Xavier Scott; Leni Grace Mathew
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

5.  Infantile cortical hyperostosis and COL1A1 mutation in four generations.

Authors:  Paola Cerruti-Mainardi; Giacomo Venturi; Marianna Spunton; Elena Favaron; Michela Zignani; Sandro Provera; Bruno Dallapiccola
Journal:  Eur J Pediatr       Date:  2011-05-13       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.